First Time Loading...

Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 1.79 CAD 1.13% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

MDP Price Targets Summary
Medexus Pharmaceuticals Inc

Wall Street analysts forecast MDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDP is 3.27 CAD with a low forecast of 2.02 CAD and a high forecast of 6.2 CAD.

Lowest
Price Target
2.02 CAD
13% Upside
Average
Price Target
3.27 CAD
83% Upside
Highest
Price Target
6.2 CAD
246% Upside
Medexus Pharmaceuticals Inc Competitors:
Price Targets
300086
Honz Pharmaceutical Co Ltd
393% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
27% Downside
VETO
Vetoquinol SA
17% Upside
ELAN
Elanco Animal Health Inc
34% Upside
KOTRA
Kotra Industries Bhd
18% Upside
NGM
NGM Biopharmaceuticals Inc
10% Upside
IPN
Ipsen SA
11% Upside
4516
Nippon Shinyaku Co Ltd
59% Upside

Revenue
Forecast

Revenue Estimate
Medexus Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 56%. The projected CAGR for the next 4 years is 4%.

56%
Past Growth
4%
Estimated Growth
Estimates Accuracy
16%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 4 years is 26%.

N/A
Past Growth
26%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Medexus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDP's stock price target?
Price Target
3.27 CAD

According to Wall Street analysts, the average 1-year price target for MDP is 3.27 CAD with a low forecast of 2.02 CAD and a high forecast of 6.2 CAD.

What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 56%. The projected CAGR for the next 4 years is 4%.

What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
26%

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 4 years is 26%.